Literature DB >> 16958424

Risk factors for enlargement of cardiac silhouette on chest radiography after radiotherapy for esophageal cancer.

Ryuta Sasamoto1, Emiko Tsuchida, Tadashi Sugita, Yasuo Matsumoto, Eisuke Abe, Keisuke Sasai.   

Abstract

PURPOSE: To evaluate the incidence and risk factors of enlargement of cardiac silhouette on chest radiographs after radiotherapy for esophageal cancer.
MATERIALS AND METHODS: We analyzed 67 patients with esophageal cancer who received external beam radiation therapy with a total dose of >or=50 Gy and were followed for >or=6 months. Sixteen patients received radiation alone, and the remaining 51 received chemoradiotherapy. The difference between the cardiothoracic ratio (CTR) on the pretreatment chest radiograph and that on the posttreatment radiograph with maximum cardiac silhouette for each patient was used for the analysis.
RESULTS: The average maximum increase in CTR for the entire group was 4.5%, which was statistically significant. Only the area of the cardiac silhouette in the initial radiation field was a significant risk factor for enlargement of the cardiac silhouette. Pericardial effusions were observed in all patients who underwent computed tomography with severe enlargement of the cardiac silhouette.
CONCLUSION: The CTR value significantly increased after radiotherapy for esophageal cancer. Radiation-induced pericardial effusion may be the main cause of enlargement of the cardiac silhouette. The irradiated cardiac area was the only significant risk factor for enlargement of the cardiac silhouette; the use of chemotherapy was not.

Entities:  

Mesh:

Year:  2006        PMID: 16958424     DOI: 10.1007/s11604-006-0050-1

Source DB:  PubMed          Journal:  Radiat Med        ISSN: 0288-2043


  16 in total

1.  Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications.

Authors:  R J Carmel; H S Kaplan
Journal:  Cancer       Date:  1976-06       Impact factor: 6.860

2.  Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.

Authors:  Paolo Bidoli; Emilio Bajetta; Simonetta C Stani; Candis Daniela De; Armando Santoro; Maurizio Valente; Roberto Zucali; Pinuccia Valagussa; Gianni Ravasi; Gianni Bonadonna
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

3.  Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results.

Authors:  P H Hardenbergh; M T Munley; G C Bentel; R Kedem; S Borges-Neto; D Hollis; L R Prosnitz; L B Marks
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

Review 4.  Radiation injury to the heart.

Authors:  J R Stewart; L F Fajardo; S M Gillette; L S Constine
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

5.  A case of refractory bilateral pleural effusion due to post-irradiation constrictive pericarditis.

Authors:  Natsuo Yamamoto; Yoshiaki Noda; Yoshihiro Miyashita
Journal:  Respirology       Date:  2002-12       Impact factor: 6.424

Review 6.  Fluorouracil cardiotoxicity.

Authors:  A J Anand
Journal:  Ann Pharmacother       Date:  1994-03       Impact factor: 3.154

7.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.

Authors:  Satoshi Ishikura; Keiji Nihei; Atsushi Ohtsu; Narikazu Boku; Shuichi Hironaka; Kiyomi Mera; Manabu Muto; Takashi Ogino; Shigeaki Yoshida
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  Pericarditis and myocardial infarctions after Hodgkin's disease therapy.

Authors:  J M Cosset; M Henry-Amar; B Pellae-Cosset; P Carde; T Girinski; M Tubiana; M Hayat
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-07       Impact factor: 7.038

9.  Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.

Authors:  Nicolas Tsavaris; Christos Kosmas; Maria Vadiaka; Michalis Efremidis; Andreas Zinelis; Dimitris Beldecos; Dimitris Sakelariou; Christos Koufos; George Stamatelos
Journal:  Med Sci Monit       Date:  2002-06

10.  Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma.

Authors:  K Sakai; H Inakoshi; H Sueyama; J Oda; T Ito; E Tsuchida; T Sugita; Y Matsumoto; M Saito; A Saito
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-02-15       Impact factor: 7.038

View more
  2 in total

1.  Treatment with Corticosteroid for Pericardial Effusion in a Patient with Advanced Synchronous Esophageal and Gastric Cancers following Chemoradiotherapy.

Authors:  Satoshi Osawa; Takanori Yamada; Takeji Saitoh; Takashi Kosugi; Tomohiro Terai; Yasuhiro Takayanagi; Yasushi Hamaya; Ken Sugimoto; Mutsuhiro Ikuma
Journal:  Case Rep Gastroenterol       Date:  2010-07-24

2.  Factors relevant to the prognosis of patients with esophageal cancer who received intensity-modulated radiotherapy.

Authors:  Hongmei Yin; Duojie Li; Chaomang Zhu; Mingxi Wang; Nannan Wei
Journal:  Thorac Cancer       Date:  2018-08-01       Impact factor: 3.500

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.